After intratumor injection, mPEI/M1mt significantly potentiated anti‐PD‐L1 in combating tumor growth and metastasis by increasing the tumor infiltration and tumoricidal effects of CD4+ and CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.